NGOC-THUY BUI: Open Payments
NPI 1306080361 · GRETNA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$601 in 29 payments from 10 companies in 2025. Trend: 2023 $802 · 2024 $676 · 2025 $601
Food & beverage: $601
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $173 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $137 |
| Lilly USA, LLC | 4 | $68 |
| Gilead Sciences, Inc. | 2 | $48 |
| Indivior Inc. | 1 | $39 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Novo Nordisk Inc | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Seqirus USA Inc | 1 | $19 |
| Exact Sciences Corporation | 1 | $15 |
Products named: JARDIANCE, BREZTRI, MOUNJARO, SUBLOCADE, FARXIGA, SHINGRIX, Ozempic, Kerendia.
Industry payments across LA — which companies pay providers there.
